Conjugated Estrogen in Late-Onset Hemorrhagic Cystitis Associated with Hematopoietic Stem Cell Transplantation
Authors:
Open Access
- 1 January 2017
- journal article
- Vol. 11 (1) , 13-18
Abstract
Background: Hemorrhagic cystitis (HC) is one of the most challenging complications in hematopoietic stem cell transplantation (HSCT). Estrogen is one of the suggested treatments for controlling this problem.Keywords
This publication has 28 references indexed in Scilit:
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Incidence, Clinical Outcome, and Management of Virus-Induced Hemorrhagic Cystitis in Children and Adolescents after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2005
- Encouraging results in the treatment of haemorrhagic cystitis with estrogen – report of 10 cases and review of the literatureBone Marrow Transplantation, 2000
- Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplantBone Marrow Transplantation, 1999
- Adenovirus Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 1999
- Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydrationBone Marrow Transplantation, 1999
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Association of BK Viruria with Hemorrhagic Cystitis in Recipients of Bone Marrow TransplantsNew England Journal of Medicine, 1986
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985
- Urological Complications of CyclophosphamideBritish Journal of Urology, 1973